What weight loss medication will Medicare pay for?

Standard Medicare Part D does not cover medications prescribed solely for weight loss, but a temporary program called the Medicare GLP-1 Bridge covers specific weight loss drugs for eligible members with a $50 monthly copay.

The Temporary Medicare GLP-1 Bridge Program

• Timeline: Active from July 1, 2026, through December 31, 2027.
• Cost: $50 monthly copay, regardless of your income.
• Covered Drugs:
  • Foundayo (oral tablets)
  • Wegovy (injections and tablets)
  • Zepbound (KwikPen format only; single-dose pens and vials are excluded)
• Basic Eligibility Rules:
  • You must be enrolled in Medicare Part D.
  • You must be 18 or older.
  • You must meet specific body mass index (BMI) and health condition requirements (such as a BMI of 35+, or a lower BMI with conditions like high blood pressure or heart disease history).
  • You do not qualify for this bridge program if you already have GLP-1 coverage through your Part D plan, or if you are being treated for type 2 diabetes, sleep apnea, or fatty liver disease.

You can check more details on the Medicare GLP-1 Bridge PDF Publication or talk directly with your doctor.

Standard Medicare Part D Rules

• General Exclusion: Federal law blocks standard Part D plans from covering anti-obesity drugs when used strictly for weight reduction or cosmetic weight management.
• Medical Exceptions: Standard Part D does cover certain GLP-1 medications (like Ozempic or Mounjaro) if they are prescribed for FDA-approved medical conditions such as Type 2 diabetes or cardiovascular risk reduction, rather than simple weight loss.

The most affordable brand-name GLP-1 option starting out is oral semaglutide or newer self-pay options like Foundayo (orforglipron) and introductory Wegovy pills, which start around $149 per month for cash-paying patients.

Affordable Brand-Name and Cash-Pay Options

• Foundayo (orforglipron): Starts around $149 per month for out-of-pocket cash buyers.
• Wegovy / Ozempic pills: Introductory cash prices start at about $149 to $199 per month through direct pharmacy or discount programs.
• Zepbound KwikPens: Cash prices start around $299 per month.
• Manufacturer Savings Cards: If you have commercial health insurance, copay cards can lower brand-name prescriptions (like Ozempic or Wegovy) to as low as $25 per month (they do not work for uninsured or government insurance like Medicare).

Alternative and Compounded Paths

• Compounded Semaglutide: Prepared by licensed compounding pharmacies, these unapproved alternatives often cost between $100 and $300 per month. They lack strict FDA approval and oversight, carrying quality and safety risks.
• Older Alternatives: Generic oral diabetes medications like metformin are significantly cheaper (often under $10 per month) and improve insulin sensitivity, though they are not true GLP-1 receptor agonists.

Yes, Medicare pays for GLP-1 drugs in 2026 under specific conditions, and a temporary program now covers select medications for weight loss.

Standard Part D Coverage for Medical Conditions

Medicare Part D plans regularly cover GLP-1 medications (like Ozempic or Wegovy) if they are prescribed for FDA-approved medical conditions other than pure cosmetic weight loss. This includes treating:

• Type 2 diabetes
• Cardiovascular risk reduction (preventing heart attacks or strokes)
• Sleep apnea or specific liver diseases like MASH

The Medicare GLP-1 Bridge Program (Weight Loss)

For weight management and obesity, standard Part D plans do not cover GLP-1 drugs. However, the Centers for Medicare & Medicaid Services (CMS) launched the temporary Medicare GLP-1 Bridge program on July 1, 2026, which runs through December 31, 2027.

• Covered Drugs: Foundayo (tablet), Wegovy (injection and tablet), and Zepbound (KwikPen only).
• Cost: A fixed $50 monthly copayment for a 30-day supply. This cost does not count toward your yearly Part D out-of-pocket maximum.
• Basic Eligibility: You must be enrolled in Medicare Part D, be 18 or older, meet specific Body Mass Index (BMI) and health risk criteria (such as a BMI of 35+ or a lower BMI with weight-related conditions like high blood pressure), and lack existing GLP-1 coverage through other parts of Part D.
• Requirements: Your doctor must submit a prior authorization request proving you meet the clinical criteria and take part in a lifestyle program.

With Medicare Part D coverage for Type 2 diabetes, your monthly cost for Ozempic typically starts between $250 and $400 until you meet your annual out-of-pocket cap, after which the cost drops to $0.

Coverage and Qualification Rules

• Approved Uses: Medicare Part D plans cover Ozempic only when prescribed for FDA-approved conditions like Type 2 diabetes.
• Weight Loss Exclusions: Medicare does not cover Ozempic or similar GLP-1 medications when prescribed solely for weight loss.
• Plan Requirements: Most plans require prior authorization from your doctor to confirm your Type 2 diabetes diagnosis before approving coverage.

Out-of-Pocket Costs in 2026

• List Price: The retail list price for a one-month supply of Ozempic is about $935 to $1,027 without insurance.
• Deductible and Coinsurance: With Part D coverage, you pay your plan’s deductible (up to $615 in 2026) and then typically a 25% coinsurance for the drug.
• Out-of-Pocket Maximum: Under current rules, total out-of-pocket spending for covered Part D drugs is capped at $2,100 for the year. Because Ozempic is expensive, most patients hit this $2,100 cap within two to three months. Once reached, your refills cost $0 for the rest of the calendar year.
• Payment Options: You can use the Medicare Prescription Payment Plan to spread these upfront costs into smaller monthly payments.

You can check specific co-pay estimates and formulary tiers using tools like the GoodRx Medicare Coverage Guide.

Original Medicare does not cover commercial weight-loss programs (like Weight Watchers or Nutrisystem), meal delivery, or gym memberships, but it does cover specific behavioral counseling, surgeries, and a temporary medication program.

Covered Medical and Behavioral Services

• Intensive Behavioral Therapy (IBT): Covered under Part B at no cost if your Body Mass Index (BMI) is 30 or higher. This includes dietary assessments and weekly or monthly counseling sessions with your primary care doctor.
• Bariatric Surgery: Covered under Part B for individuals with a BMI of 35 or higher who have obesity-related health conditions (like diabetes or heart disease) and have tried other methods without success. Approved procedures include gastric bypass and sleeve gastrectomy.
• Medical Nutrition Therapy (MNT): Covered if you have diabetes, kidney disease, or have received a kidney transplant, provided by a registered dietitian.

Weight Loss Medications and the GLP-1 Bridge Program

• Medicare GLP-1 Bridge Program: Starting in July 2026, a temporary program covers specific weight-loss drugs (Wegovy, Zepbound, and Foundayo) for eligible Part D members with a flat $50 monthly copay. You can read more about it through the Medicare GLP-1 Bridge Publication.
• Standard Part D Rules: Historically, standard Part D plans exclude drugs prescribed solely for cosmetic weight loss, though they do cover GLP-1 medications if prescribed for approved conditions like type 2 diabetes or cardiovascular risk reduction.

Medicare Advantage (Part C)

• Private Medicare Advantage plans may offer extra benefits that Original Medicare excludes. These can include gym memberships (such as SilverSneakers) or specific wellness and healthy-food delivery programs. Check details directly with your Medicare Plan Provider.